Redeye: ÅAC Microtec - Improving order backlog

The Q1-numbers were a bit lower than we expected. But as we learned from last year, fluctuations are significant between the quarters. We are still optimistic about the near term outlook thanks to some improvement in business momentum and a solid order backlog.

Read more and download the latest research update: 

Become a member at Redeye to access the latest research on Life Science and Tech companies.

This is a press release from Redeye - Research Powered Investment Banking: